Literature DB >> 2344212

HLA antigens in psoriatic arthritis subtypes of a Spanish population.

C López-Larrea1, J C Torre Alonso, A Rodriguez Perez, E Coto.   

Abstract

HLA-A, B, and C antigens were studied in 104 Spanish patients with psoriatic arthritis. Different clinical features were evaluated and the patients divided into disease subsets. HLA-B17, B27, B16, and Cw6 were the most common haplotypes in the total group. The HLA-B17/Cw6 haplotype was increased in patients with oligoarthritis. The increase of antigen B17 correlated with oligoarthritis and spondarthritis, whereas Cw6 was more significant in oligoarthritis. The prevalence of the B27/Cw1 haplotype was greater in association with spondarthritis and was probably related to the B27.5 subtype linked to Cw1. A significant negative association between the B44/Cw5 haplotype and psoriatic arthritis was found. The existence of several haplotypic factors in the different subsets is discussed. Lack of one or more HLA factors is thought to be responsible for the different clinical forms of psoriatic arthritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344212      PMCID: PMC1004077          DOI: 10.1136/ard.49.5.318

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Different linkage disequilibria of HLA-B27 subtypes and HLA-C locus alleles.

Authors:  B S Breur-Vriesendorp; L P de Waal; P Ivanyi
Journal:  Tissue Antigens       Date:  1988-08

Review 2.  Psoriatic arthritis.

Authors:  J M Moll; V Wright
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

Review 3.  Histocompatibility typing in the seronegative spondyloarthropathies: a survey.

Authors:  L R Espinoza; F B Vasey; S W Gaylord; C Dietz; L Bergen; P Bridgeford; B F Germain
Journal:  Semin Arthritis Rheum       Date:  1982-02       Impact factor: 5.532

4.  HLA antigens in a sample of the Spanish population: common features among Spaniards, Basques, and Sardinians.

Authors:  A Arnaiz-Villena; S Rodriguez de Córdoba; F Vela; J C Pascual; J Cerveró; A Bootello
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

5.  Histocompatibility antigens in psoriatic arthritis.

Authors:  J R Lambert; V Wright; S M Rajah; J M Moll
Journal:  Ann Rheum Dis       Date:  1976-12       Impact factor: 19.103

6.  HLA-A,B,C and DR antigens in psoriasis.

Authors:  J A Marcusson; A Johannesson; E Möller
Journal:  Tissue Antigens       Date:  1981-05

7.  HLA antigens in psoriatic arthritis.

Authors:  D D Gladman; K A Anhorn; R K Schachter; H Mervart
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

8.  Frequency of HLA antigens in patients with psoriasis or psoriatic arthritis.

Authors:  R J McKendry; D P Sengar; J P DesGroseilliers; J V Dunne
Journal:  Can Med Assoc J       Date:  1984-02-15       Impact factor: 8.262

9.  Psoriasis and HLA-Cw6.

Authors:  A Tiilikainen; A Lassus; J Karvonen; P Vartiainen; M Julin
Journal:  Br J Dermatol       Date:  1980-02       Impact factor: 9.302

10.  Psoriatic arthritis: clinical subgroups and histocompatibility antigens.

Authors:  N J McHugh; M R Laurent; B L Treadwell; J M Tweed; J Dagger
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

View more
  11 in total

Review 1.  Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review.

Authors:  Andrea Sukhov; Iannis E Adamopoulos; Emanual Maverakis
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

2.  Comparison of MHC class I risk haplotypes in Thai and Caucasian psoriatics shows locus heterogeneity at PSORS1.

Authors:  P E Stuart; R P Nair; R Hiremagalore; P Kullavanijaya; P Kullavanijaya; T Tejasvi; H W Lim; J J Voorhees; J T Elder
Journal:  Tissue Antigens       Date:  2010-08-19

3.  Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis.

Authors:  T Höhler; S Grossmann; B Stradmann-Bellinghausen; W Kaluza; E Reuss; K de Vlam; E Veys; E Märker-Hermann
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

4.  HLA-B27 frequency in a group of patients with psoriatic arthritis.

Authors:  Danilo Garcia Ruiz; Mário Newton Leitão de Azevedo; Omar Lupi
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

5.  Association of HLA Alleles and HLA Haplotypes with Psoriasis, Psoriatic Arthritis and Disease Severity in a Miscegenated Population.

Authors:  Flavia de Freire Cassia; Juliana Fernandes Cardoso; Luiz Cristovao Porto; Marcia Ramos-E-Silva; Sueli Carneiro
Journal:  Psoriasis (Auckl)       Date:  2021-05-10

6.  Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis.

Authors:  P Y P C Ho; A Barton; J Worthington; D Plant; C E M Griffiths; H S Young; P Bradburn; W Thomson; A J Silman; I N Bruce
Journal:  Ann Rheum Dis       Date:  2007-08-29       Impact factor: 19.103

7.  HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis.

Authors:  Ruben Queiro; Segundo Gonzalez; Carlos López-Larrea; Mercedes Alperi; Cristina Sarasqueta; Jose Luis Riestra; Javier Ballina
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 8.  The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis.

Authors:  Matteo Vecellio; Vivien Xanath Hake; Connor Davidson; Maria Cristina Carena; B Paul Wordsworth; Carlo Selmi
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

Review 9.  Genetic epidemiology. Psoriatic arthritis.

Authors:  Anne C Barton
Journal:  Arthritis Res       Date:  2002-01-31

10.  Associations between human leukocyte antigen C locus polymorphism and psoriatic arthritis in populations of European and Middle Eastern descent: a meta-analysis.

Authors:  Lin-Nan Shao; Ni Wang; Shi-Hang Zhou; Zi Wang
Journal:  Ann Saudi Med       Date:  2020-08-06       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.